(Total Views: 581)
Posted On: 06/25/2020 11:54:13 AM
Post# of 154119
Quote:This is the best (and funniest) description of what probably happened.
"why the hell are you requesting a BTD with 4 patients?"
I know things have been a tad busy back at the shop, but the current expiration for those BTD incentive shares sunsets on July 28, 2020, just about one month from today.
Hard to imagine how there would be time for that "post-liminary" meeting, followed by a new BTD submission, followed by an official approval.
Maybe this initiative was unavoidably derailed by the lack of being able to collect trial data due to the pandemic. Or, maybe the board will simply agree to extend the expiration date for the very same reason.
Quote:
On January 28, 2020, the Company awarded 11,650,000 performance shares to certain of its directors and executive officers outside of the 2012 Plan. The awards will vest and be settled in shares of common stock of the Company if the Company achieves FDA Breakthrough Therapy designation for cancer within 6 months of the award date and if certain other requirements have been met
That means, this incentive bump sunsets on July 28, 2020, just about two months from now.
(1)
(0)
